Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression

Nature Medicine

Volumn 5, Issue 5, 1999, Pages 535-541

  Kimata, Jason T ^a   Kuller, LaRene ^a   Anderson, David B ^a   Dailey, Peter ^b   Overbaugh, Julie ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIGENIC VARIATION; ARTICLE; CYTOPATHOGENIC EFFECT; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; MONKEY DISEASE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS PATHOGENESIS;

EID: 0032922339     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/8414     Document Type: Article

References (45)

1. Åsjö, B. et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet II, 660-662 (1986).
2. Cheng-Mayer, C., Seto, D., Tateno, M. & Levy, J.A. Biologic features of HIV-1 that correlate with virulence in the host. Science 240, 80-82 (1988).
3. Connor, R.I., Mohri, H., Cao, Y. & Ho, D.D. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67, 1772-1777 (1993).
4. Connor, R.I. & Ho, D.D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68, 4400-4408 (1994).
5. Fenyö, E.M., et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62, 4414-4419 (1988).
6. Fenyö, E.M., Albert, J. & Åsjö, B. Replicative capacity, cytopathic effects and cell tropism of HIV. AIDS 3 (suppl), S5-S12 (1989).
7. Schuitemaker, H. et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66, 1354-1360 (1992).
8. Tersmette, M. et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet I, 983-985 (1989).
9. Tersmette, M. et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63, 2118-2125 (1989).
10. Fiore, J.R. et al. The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204, 297-303 (1994).
11. Nielsen, C., Pedersen, C., Lundgren, J.D. & Gerstoft, J. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 7, 1035-1040 (1993).
12. Glushakova, S. et al. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nature Med. 4, 346-349 (1998).
13. Zack, J.A. & Overbaugh, J. SIV and HIV pathogenesis in animal systems. AIDS 8 (suppl 1), S43-S52 (1994).
14. Levy, J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289 (1993).
15. Fultz, P.N., McClure, H.M., Anderson, D.C. & Switzer, W.M. Identification and biological characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res. Hum. Retroviruses 5, 397-409 (1989).
16. Reimann, K.A. et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus macaques. J. Virol. 70, 6922-6928 (1996).
17. Joag, S.V. et al. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in Pig-tailed macaques. J. Virol. 70, 3189-3197 (1996).
18. Edmonson, P. et al. Evolution of a simian immunodeficiency virus pathogen. J. Virol. 72, 405-414 (1998).
19. Kimata, J.T. & Overbaugh, J. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env. J. Virol. 71, 7629-7639 (1997).
20. Morton, W.R. et al. Transmission of the simian immunodeficiency virus SIVmne in macaques and baboons. J. Med. Primatol. 18, 237-245 (1989).
21. Overbaugh, J., Rudensey, L.M., Papenhausen, M.D., Benveniste, R.E. & Morton, W.R. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J. Virol. 65, 7025-7031 (1991).
22. Rudensey, L.M., Kimata, J.T., Benveniste, R.E. & Overbaugh, J. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 207, 528-542 (1995).
23. Rudensey, L.M., Kimata, J.T., Long, E.M., Chackerian, B. & Overbaugh, J. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J. Virol. 72, 209-217 (1998).
24. Chackerian, B., Rudensey, L.M. & Overbaugh, J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 71, 7719-27 (1997).
25. Overbaugh, J. & Rudensey, L.M. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques. J. Virol. 66, 5937-5948 (1992).
26. Kimata, J.T., Mozaffarian, A. & Overbaugh, J. A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. J. Virol. 72, 245-256 (1998).
27. Hirsch, V.M. et al. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effects of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70, 3741-3752 (1996).
28. Mellors, J.W. et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122, 573-579 (1995).
29. Mellors, J.W. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170 (1996).
30. O'Brien, W.A. et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334, 426-431 (1996).
31. O'Brien, T.R. et al. Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study. J. Am. Med. Assoc. 276, 105-110 (1996).
32. Watson, A. et al. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71, 284-290 (1997).
33. Mellors, J.W. et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126, 946-954 (1997).
34. Connor, R.I. & Ho, D.D. Transmission and pathogenesis of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 10, 321-323 (1994).
35. Miedema, F. et al. Changing virus-host interactions in the course of HIV-1 infection. Imm. Rev. 140, 35-72 (1994).
36. MAC). Virology 183, 12-19 (1991).
37. Kestler, H. et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109-1112 (1990).
38. Desrosiers, R.C. et al. Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS. Am. J. Pathol. 139, 29-35 (1991).
39. Kimata, J.T. et al. Coreceptor specificity of temporal variants of SIVMne. J. Virol. (in the press).
40. Chackerian, B., Long, E.M., Luciw, P.A. & Overbaugh, J. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71, 3932-3939 (1997).
41. Reitter, J.N., Means, R.E. & Desrosiers, R.C. A role for carbohydrates in immune evasion in AIDS. Nature Med. 4, 679-684 (1998).
42. Dailey, P.J., Zamround, M., Kelso, R., Kolberg, J. & Urdea, M. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected macaques using a branched DNA (bDNA) signal amplification assay. J. Med. Primatol. 24, 209 (1995).
43. Connor, R.I. et al. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72, 7501-7509 (1998).
44. Harris, M. et al. Correlation of viral load in plasma and lymph node tissue in HIV infection. J. Infect. Dis. 176, 1388-1392 (1997).
45. Marx, P.A. et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med 2, 1084-1089 (1996).